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Abstract
Occurrence of intraspecific variation in parasite virulence, a prerequisite for coevolution of hosts and parasites, has largely
been reported. However, surprisingly little is known of the molecular bases of this variation in eukaryotic parasites, with the
exception of the antigenic variation used by immune-evading parasites of mammals. The present work aims to address this
question in immune suppressive eukaryotic parasites. In Leptopilina boulardi, a parasitic wasp of Drosophila melanogaster,
well-defined virulent and avirulent strains have been characterized. The success of virulent females is due to a major
immune suppressive factor, LbGAP, a RacGAP protein present in the venom and injected into the host at oviposition. Here,
we show that an homologous protein, named LbGAPy, is present in the venom of the avirulent strain. We then question
whether the difference in virulence between strains originates from qualitative or quantitative differences in LbGAP and
LbGAPy proteins. Results show that the recombinant LbGAPy protein has an in vitro GAP activity equivalent to that of
recombinant LbGAP and similarly targets Drosophila Rac1 and Rac2 GTPases. In contrast, a much higher level of both mRNA
and protein is found in venom-producing tissues of virulent parasitoids. The F1 offspring between virulent and avirulent
strains show an intermediate level of LbGAP in their venom but a full success of parasitism. Interestingly, they express
almost exclusively the virulent LbGAP allele in venom-producing tissues. Altogether, our results demonstrate that the major
virulence factor in the wasp L. boulardi differs only quantitatively between virulent and avirulent strains, and suggest the
existence of a threshold effect of this molecule on parasitoid virulence. We propose that regulation of gene expression
might be a major mechanism at the origin of intraspecific variation of virulence in immune suppressive eukaryotic parasites.
Understanding this variation would improve our knowledge of the mechanisms of transcriptional evolution currently under
active investigation.
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Introduction
Models of host-parasite coevolution all assume occurrence of
genetic variation for host resistance and parasite virulence, such as
well-described for plant-pathogen interactions [1] and in a few
host-parasite models [2][3]. Advances in understanding coevolu-
tionary interactions thus require unraveling the molecular bases of
host resistance and parasite virulence, and then acquiring data
on how polymorphism in genes controlling these traits affect
parasitism success in the field [4]. This will enable direct observa-
tion, rather than inference, of the host-parasite coevolutionary
dynamics.
One largely unaddressed question in eukaryotic parasites is the
basis of intraspecific variation of virulence. Regarding immune
aspects, the only described mechanism is, to our knowledge, the
antigenic variation used by fungal and protozoan parasites to hide
themselves from the mammalian immune system [5–10]. Whether
changes associated with virulence variation in immune suppressive
parasites are qualitative and/or quantitative and what is their
nature, still remain to be assessed.
The biological models of interacting species that satisfy all the
requirements to study coevolutionary processes, from molecular
tools to population polymorphisms, are scarce and Drosophila-
parasitoid wasps interactions are undoubtedly among the best of
them [11]. Variation in both Drosophila resistance and parasitoid
virulence is observed in the field [12–14], and some major genes
involved in these traits have been characterized [15–18]. Based
on these data, we address here the question of the origin of
intraspecific variation of virulence of Drosophila parasitoids.
Endoparasitoid wasps develop inside the body of their
arthropod host, which will die as a result of the interaction
[19],[20]. To face the immune defense of the host, they have
evolved original strategies ranging from displaying surface features
that prevent their recognition to altering components of the host
immune system using venom proteins, virus-like particles or wasp-
specific viruses, polydnaviruses [21],[22]. However, occurrence of
virulence variation together with molecular identification and
characterization of the factors involved in immune suppres-
sion has only been reported in the wasp Leptopilina boulardi
[15],[16],[23],[24].
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in the formation of a multicellular melanized capsule around the
wasp egg that results in the death of the parasitoid [25].
Plasmatocytes first attach to the parasitoid egg and spread around
it, then lamellocytes adhere to them to form multiple cell layers
[26],[27].
Two types of L. boulardi wasps have been described based on
their virulence properties against Drosophila hosts. The ISm
isofemale line, highly virulent against D. melanogaster (and so-called
‘‘virulent’’ line) is representative of Mediterranean L. boulardi wasps
both in its virulence properties and venom protein profile
[23],[28]. It produces in its venom a RacGAP domain-containing
protein, named LbGAP, whose injection in D. melanogaster larvae
mimics the egg protection provided by parasitism [23],[24],[29].
LbGAP has a RacGAP activity and induces changes in the
morphology of D. melanogaster lamellocytes [23],[24]. It specifically
interacts with and inactivates two Drosophila Rho GTPases, Rac1
and Rac2 [15], both required for successful encapsulation of
Leptopilina eggs [27],[30]. Interestingly, ISm wasps are not
virulent against the host species D. yakuba, and, accordingly, host
lamellocytes remain unchanged in presence of ISm venom [31].
By contrast, the success of the ISy isofemale line of L. boulardi
depends on the host phenotype and it was then called ‘‘avirulent’’
[12],[13]. This line originates from Congo, where variation of
parasitism success toward D. melanogaster was observed, due to
occurrence of a polymorphism in the L. boulardi virulence
phenotype [13],[28]. This polymorphism is likely due to the fact
that several Drosophila host species are available in tropical Africa
that can successfully be parasitized, and that virulence toward D.
melanogaster may be costly for the parasitoid [13],[28]. Using the
avirulent ISy line, resistant and susceptible D. melanogaster reference
strains were obtained from a sympatric Congolese D. melanogaster
population [32]. However, resistance to ISy parasitoids is not
restricted to Congo but is present at high frequencies in tropical as
well as Mediterranean host populations [13].
ISy parasitoids are able to suppress the immune defenses of
susceptible larvae of D. melanogaster as well as of other host species
such as D. yakuba [12],[16]. However, their parasitism success is
not associated with an alteration of the host lamellocyte shape
[24],[31]. Accordingly, at the protein level, no major band of the
size of LbGAP was observed in electrophoretic analysis of ISy
venom producing tissues [23]. Taken together, all these data point
to LbGAP as a major virulence factor in Mediterranean L. boulardi
parasitoids, involved in variation of parasitism success against D.
melanogaster. In ISy tropical parasitoids, the venom contains a
serpin that alters melanisation in the hemolymph of D. yakuba
larvae [16], and might be responsible for the delayed encapsula-
tion induced by injection of total venom [31]. The way ISy females
counteract the immune defenses of susceptible D. melanogaster flies
is yet totally unknown.
In this study, we first confirm that LbGAP is required for
virulence against resistant D. melanogaster hosts. We demonstrate
that both the virulent and avirulent parasitoid lines produce a
RacGAP protein in their venom, and we report the sequence of
the RacGAP gene homologous to LbGAP from the avirulent line
(LbGAPy). We then compare the activity of LbGAP and LbGAPy
proteins, their level of interaction with their Rac targets and their
localization in the lamellocytes of parasitized hosts. Finally, we
present quantitative data on LbGAP and LbGAPy at the mRNA
and protein levels on virulent, avirulent, and F1 parasitoids.
Results show that differences between virulent and avirulent
parasitoids regarding the RacGAP toxin are only quantitative and
very likely due to variation in cis-regulation of gene expression.
Results
LbGAP is necessary for L. boulardi virulence
Previous work had shown that LbGAP is sufficient for successful
parasitism of resistant D. melanogaster hosts by virulent parasitoid
females. In order to determine whether this factor is also necessary
for virulence, we performed experiments of injection of ISm
venom in resistant D. melanogaster larvae, which is known to protect
avirulent ISy eggs from encapsulation [24],[29]. In the present
work, ISm venom was incubated before injection either with a
specific polyclonal antibody against LbGAP or with the pre-
immune serum as a control, and larvae were then submitted to
parasitism by ISy females. Venom incubated with the preimmune
serum conferred active protection to avirulent eggs, with only
18.6% of encapsulation (Figure 1A). By contrast, incubation of
ISm venom with the antibody against LbGAP led to 75.9% of
avirulent eggs being encapsulated (Chi2=38.43 ; ddl=1;
p,0.001). A second experiment was performed in which the
LbGAP antibody or the preimmune serum were injected alone
into resistant host larvae that were subsequently parasitized by
virulent ISm parasitoids. The encapsulation rates were 0% with
the preimmune serum and 34.8% following injection of the
LbGAP antibody, respectively (Chi2=24.49 ; ddl=1 ; p,0.001;
Figure 1B). These results demonstrate that LbGAP is a venom
protein needed for L. boulardi virulence against resistant D.
melanogaster flies.
A LbGAP homolog in the ISy L. boulardi line
Whether an homolog of LbGAP is expressed in ISy parasitoids
was questioned by performing PCR experiments on cDNAs from
ISy venom-producing tissues, using primers designed from the
sequence of LbGAP [23]. A 914 bp amplicon was obtained whose
sequence contains a 861 bp ORF (GenBank accession number
GU300066) encoding a predicted protein of 286 amino acids that
was named LbGAPy (Figure 2A). Like LbGAP, this protein starts
with a N-terminal signal peptide of 20 amino acids allowing its
extracellular export, and it contains a RhoGAP domain. The
nucleotide sequences of LbGAP and LbGAPy are 95.2% identical,
while LbGAP and LbGAPy proteins share 89.5% identity and
Author Summary
Evolutionary theories that discuss evolution of virulence in
parasite species rely on the assumption that there is
additive genetic variation for virulence traits, and that
some alleles can then be readily selected, for instance
following changes in host resistance genotypes. However,
the molecular bases of this variation remain to be
deciphered to better estimate the potential for evolution
of virulence. This approach has been fruitful to understand
evolution of insect resistance to insecticides, with point
mutations, gene amplification and changes in expression
level as possible sources of genetic variation. Parasitoids,
auxiliaries used for biological control of insect pests,
provide excellent models to study the coevolutionary
processes that may drive changes in parasite host range.
We describe here for the first time a mechanism at the
origin of the intraspecific variation of virulence in a
parasitoid wasp, a model for immune suppressive eukary-
otic parasites, through regulation of the transcription of a
major virulence factor. This study represents a new step in
understanding both the evolutionary origin of virulence
factors and their intraspecific variation, which may help
optimize biological control success in the field.
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acid residues Arg74, Lys111, Arg115 and Ser190, described to be
involved in LbGAP interaction with Rac GTPases [15]. Arg74 is
conserved in all GAP proteins and forms an arginine-finger that
stabilizes the GTPase invariant glutamine residue 61 or 63 to
facilitate the catalysis of GTP to GDP [33]. The main difference
between LbGAPy and LbGAP sequences is located at the C-
terminal end of the protein outside the RhoGAP domain
(Figure 2B).
RacGAP activity of LbGAPy
LbGAP was previously shown to display a GAP activity with a
strong preference for Rac-GTPases [15]. In order to determine if
LbGAPy may have a similar GAP function in host cells, we carried
out in vitro GAP assays using the LbGAPy protein produced in E.
coli. Experiments were performed with human RhoA, Rac1 and
Cdc42 Rho-GTPases. Human Ras, belonging to the Ras-GTPase
family, was included as a negative control while LbGAP as well as
the GAP domain from human p50 RhoGAP (which stimulates
GTPase activities of RhoA, Rac1 and Cdc42 in vitro), were used as
positive controls. Other negative controls consisted in the omission
of either small G-protein or GAP protein. Similarly to LbGAP,
LbGAPy significantly increased the GTPase activity of human
Rac1 and Cdc42 but not of RhoA and Ras (F=109.2; df=11;
p,0.001; Figure 3A). As for LbGAP, the GAP activity towards
Rac1 was four times higher than towards Cdc42, suggesting that
Rac-GTPases are the preferred substrates of LbGAPy as well.
Physical interaction of LbGAPy with Rac1 and Rac2
GTPases
As LbGAP is known to specifically interact with Drosophila Rac1
and Rac2 [15], we questioned whether LbGAPy similarly targets
these Rac-GTPases by performing yeast two-hybrid analyses. In
order to stabilize interactions, we used the G12V mutated forms of
Drosophila Rac1, Rac2 and Cdc42 GTPases and the G14V
mutated form of Drosophila RhoA. Each of these mutants is
deficient in GTPase activity and therefore constitutively blocked in
the GTP-bound active conformation. Fusions of the GAL4
activation domain with LbGAP were expressed in yeast together
with fusions of the LexA-DNA binding domain either with
Rac1G12V, Rac2G12V, Cdc42G12V or RhoAG14V. Direct in
vivo interaction of LbGAPy with small GTPases was measured as
the ability of transformed yeast to activate the transcription of
HIS3 and lacZ reporter genes, both under the control of the LexA-
binding sequences. Yeast growth on a selective medium lacking
histidine revealed that, similarly to LbGAP, LbGAPy interacts
with Rac1G12V and Rac2G12V but only weakly with
Cdc42G12V, and has no interaction with RhoAG14V (Figure 3B).
The strength and specificity of the interaction between LbGAPy
and Rac GTPases was then estimated by titration of ß-
galactosidase activity (Figure 3C). Substantial activity was seen
using coexpression of GAL4AD-LbGAPy and either LexABD-
Rac1G12V or LexABD-Rac2G12V but not in combination with
non-specific sequences. The beta-galactosidase activity resulting
from the interaction between LbGAPy and Rac GTPases was
similar to that obtained using LbGAP and the same Rac GTPases
(F=92.2; df=13; p,0.001; Figure 3C), thus demonstrating that
this interaction is as strong and specific as the one demonstrated
with LbGAP.
Differences in LbGAP and LbGAPy amounts in host target
cells
We previously showed that LbGAP enters plasmatocytes and
lamellocytes in ISm-parasitized D. melanogaster larvae and that
morphological changes in lamellocytes are correlated with the
intracellular quantity of LbGAP [15]. Using the polyclonal
antibody raised against LbGAP that equally recognizes LbGAPy
(see below), immunolocalization experiments were performed on
hemolymph from D. melanogaster larvae 48 hours following parasit-
ization by either ISm or ISy females. As expected, the majority of
lamellocytes from ISm-parasitized larvae had a modified morphol-
ogy and contained LbGAP (red intracytoplasmic fluorescent dots;
Figure 4A and 4B). In contrast, lamellocytes from ISy-parasitized
larvae remained largely unmodified and very few contained
LbGAPy dots (Figure 4C and 4D). Among these, the number of
dotswasusuallylessthan fivewhereasmanylamellocytesfromISm-
parasitized larvae contained more than 30 dots.
Different levels of LbGAP and LbGAPy expression in
venom-producing tissues and female residual bodies
qRT-PCR experiments were performed on ISm and ISy female
samples of the same age to quantify differences in expression levels
of LbGAP and LbGAPy genes between venom-producing tissues
and the rest of the bodies, and to compare expression levels of
LbGAP and LbGAPy in their respective parasitoid line. A 2200-fold
Figure 1. The RacGAP protein is necessary for virulence of ISm
females. (A) D. melanogaster resistant L2 larvae were injected with ISm
venom incubated either with the pre-immune serum as a control or a
specific polyclonal antibody against LbGAP, then parasitized with the
ISy avirulent line. The encapsulation rate was recorded after 48 h. In
brackets are the numbers of injected larvae. (B) D. melanogaster
resistant L2 larvae were injected with the pre-immune serum as a
control or the specific antibody against LbGAP, and then parasitized
with the ISm virulent line. The encapsulation rate was recorded after
48 h. In brackets are the numbers of injected larvae.
doi:10.1371/journal.ppat.1001206.g001
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producing tissues as compared to the rest of the female body
(Figure 5A; Student t-test : t=219.1, df=12, p,0.001).
Expression of LbGAPy was also higher in ISy venom producing
tissues than in the rest of the body, but only with a 270-fold higher
expression level (Figure 5A; Student t-test: t=216.6, df=10,
p,0.001). When comparing parasitoid strains, LbGAPy was
approximately 30 times less expressed in ISy venom-producing
tissues than LbGAP in ISm venom-producing tissues (Figure 5B;
Student t-test: t=29.4, df=15, p,0.001).
No significant difference in LbGAP and LbGAPy gene copy
number
To determine whether the difference in the number of LbGAP
and LbGAPy transcripts results from a difference in the number of
gene copy, qPCR experiments were performed on genomic DNA
from the venom-producing tissues and from the rest of the female
bodies of ISm and ISy parasitoids, respectively. No significant
differences were found between the copy number of the LbGAP
gene in ISm venom producing tissues and ISm residual female
bodies or of the LbGAPy gene in ISy venom producing tissues and
ISy residual bodies (df=3, F=1.4651, p=0.2953).
Differences in LbGAP and LbGAPy protein amounts in
venom producing tissues
In previous Western blot experiments using a specific polyclonal
antibody against the recombinant LbGAP protein, no signal was
observed in ISy venom-producing tissues, possibly because the
technique employed was not sensitive enough or because the
antibody does not recognize LbGAPy [23]. These hypotheses were
tested by producing both LbGAP and LbGAPy as GST-fusion
proteins in Escherichia coli and using them to perform dot blot
experiments on serial dilutions starting from the same quantity of
these proteins. Our results show that the antibody recognizes
specifically the LbGAP and LbGAPy recombinant proteins with
the same efficiency (Figure 6A).
We then performed dot blot experiments with serial dilutions of
total protein extracts from 20 ISm and 20 ISy venom-producing
tissues (which represent the same amount of protein), using the
anti-LbGAP polyclonal antibody. LbGAP was easily detected in
Figure 2. Sequence analysis of LbGAPy, the LbGAP homolog from the ISy L. boulardi line. (A) Schematic representation of LbGAP and
LbGAPy amino acid sequences. The signal peptide (SP) and the RhoGAP domain are shown as black and gray rectangles, respectively. (B) Sequence
alignment of LbGAP and LbGAPy amino acid sequences. Residues identical or similar are highlighted in black and grey, respectively. The signal
peptide is indicated by a dotted line. The RhoGAP domain is underlined. Stars identify LbGAP residues involved in the interaction with Rac GTPases.
doi:10.1371/journal.ppat.1001206.g002
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undiluted ISy extracts. The quantity of LbGAPy was then
estimated to be 60 times less than that of LbGAP in ISm venom
tissues (Figure 6B).
A threshold effect of LbGAP quantity on virulence?
In order to further investigate the role of LbGAP quantity in
ISm virulence, we performed crossing experiments between ISm
females and ISy males and we assessed the virulence level of the F1
offspring, as well as the LbGAP/LbGAPy quantity in F1 venom-
producing tissues, using dot-blot experiments. The amount of the
LbGAP/LbGAPy proteins in F1 venom-producing tissues was
approximately half the amount of LbGAP in ISm (Figure 6C). In
parasitism experiments with the resistant strain of D. melanogaster in
which ISy parasitoids are highly encapsulated (virulence level
5.7%), virulence of F1 hybrids (virulence level 98%) did not
significantly differ from virulence of ISm parasitoids (virulence
level 100% ; p,0.001).
Figure 3. LbGAPy displays a GAP activity in vitro and interacts with D. melanogaster Rac1 and Rac2. (A) Absorbance at 650 nm, which is
correlated with the amount of Pi released from GTP-bound human Rac1, Cdc42, RhoA or Ras, was measured in the presence of LbGAPy or LbGAP or
in the absence of any GAP. Bars: GAP activity in the presence of LbGAPy (grey bars), in the presence of LbGAP (open bars), in the absence of GAP
(black bars). For each value, error bars represent the standard error of three measurements. (B) Results based on growth on selective medium lacking
histidine and qualitative ß-galactosidase overlay assays. x : non-tested; 2 : no interaction; (+) : very weak interaction; ++ : mean interaction, ++++ :
strong interaction. (C) Interactions with Rac1G12V, Rac2G12V, Cdc42G12V, RhoAG14V and Lamin (negative control) assayed by measuring beta-
galactosidase activity in total protein extracts. Grey bars : beta-galactosidase activity in the presence of LbGAPy. Open bars : beta-galactosidase
activity in the presence of LbGAP. Black bars : beta-galactosidase activity in the presence of T antigen (negative control). For each value, error bars
represent the standard error of three measurements.
doi:10.1371/journal.ppat.1001206.g003
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under the control of cis-acting elements
To determine whether the variation of expression of LbGAP and
LbGAPy is under the control of cis-o rtrans-acting elements, we
performed PCR experiments on cDNA obtained from venom-
producing tissues of ISm, ISy and F1 females. Two sets of primers
were designed that respectively amplify LbGAP and LbGAPy and their
specificity was tested using genomic DNAextracted from total bodies:
a 670 bp and a 684 bp PCR product were amplified from ISm and
ISy females, respectively, while both fragments were amplified from
F1 individuals. Using ISm and F1 cDNAs and the LbGAP-specific
primers, an intense band corresponding to a 252 bp amplicon was
obtained. By contrast, only a faint band of 265 bp was observed using
the LbGAPy-specific primers and cDNA from ISy or F1 individuals
(Figure 7). Control of genomic DNA and cDNA quantities were
performed using the internal transcribed spacer 2 (ITS2) gene.
Overall, these results show that F1 individuals overexpress the
LbGAP and not the LbGAPy allele in venom tissues. This strongly
suggests that variation of expression of LbGAP and LbGAPy is
under the control of cis- rather than trans-acting elements.
Discussion
Intraspecific variation in virulence occurs in several eukary-
otic parasite species [31],[34–36], but it has only been explained
in some mammalian parasites such as Toxoplasma gondii,
Trypanosoma brucei or Plasmodium falciparum. In these species,
antigenic variation occurs, mediated by the differential expres-
sion of surface molecules [5–10]. In parasitoid wasps, intraspe-
cific variation in virulence has been reported in three species,
Asobara tabida, Cotesia sesamiae and L. boulardi.I nA. tabida,i ti s
associated with a difference in immunoevasion capacities [35] in
relation with the degree of embedment of the parasitoid egg in
host tissues [37],[38]. However, nothing is known of the
mechanism by which A. tabida eggs adhere to host tissues.
Parasitism success of C. sesamiae in the host Busseola fusca
relies on the suppression of host immune defenses by polydna-
viruses (PDVs) injected with the egg. Differences in the
sequence of one PDV gene (CrV1) and in its level of expression
in the host exist between virulent and avirulent parasitoids
[34],[39] but CrV1 role in virulence of C. sesamiae has not been
demonstrated.
Figure 4. LbGAP and LbGAPy are detected in lamellocytes of parasitized D. melanogaster larvae. Immunocytochemical detection of
LbGAP was performed on hemolymph collected from third-instar Drosophila larvae, 15hrs following parasitism. The LbGAP toxin is visualized as red
spots while actin is detected by green labeled phalloidin. In larvae parasitized with ISm (A and B), most lamellocytes contain numerous LbGAP spots
in their cytoplasm and their morphology is modified. In contrast, lamellocytes from larvae parasitized with ISy parasitoids are generally unchanged
and without LbGAPy spots (C), a few of them containing a small number of LbGAPy spots (D).
doi:10.1371/journal.ppat.1001206.g004
How Parasites Vary in Virulence
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extensively studied in the venom, one in each of two lines, ISm and
ISy, that display opposite virulence properties towards Drosophila
host species [15],[16],[23],[31],[40]. L. boulardi then certainly
provides the best parasitoid model to address the issue of the
molecular bases of variation in virulence of an immune suppressive
parasite.
The LbGAP protein appears as a major band in venom protein
electrophoretic patterns of all strains virulent against D. melanogaster
analyzed to date, but it was not observed in the avirulent ISy line
[23]. The demonstration that LbGAP represents a major toxin,
sufficient for parasitoid virulence toward this host species, comes
from experimental evidence that the proteins eluted from this
band, when injected into host larvae, conferred the same
protection to avirulent parasitoid eggs as injection of total ISm
venom [23],[24],[29]. Here, we show that this protection is
abolished if the venom is previously incubated with an anti-
LbGAP antibody. Also, injection of the antibody into host larvae
before parasitism significantly decreases the success of ISm
parasitoids. LbGAP is thus the main factor responsible for
protection of L. boulardi eggs in resistant D. melanogaster hosts, and
it is necessary for parasitoid virulence. This might explain why
virulence is reported to be controlled by a single chromosomal
factor despite the presence of several proteins in the venom [41].
Variation in LbGAP is then likely responsible for most of the
variation of virulence between L. boulardi strains.
Here, we show that a gene homologous to LbGAP (LbGAPy)i s
expressed in venom-producing tissues of the avirulent parasitoid
line and that the protein is present in the venom. The previous
extensive characterization of LbGAP [15],[23],[24] thus provided
a unique opportunity to assess whether variation of virulence is
due to quantitative differences in this toxin or to qualitative
changes that would impair binding to its targets or reduce its
activity.
LbGAP and LbGAPy deduced amino acid sequences are 89%
identical, and both contain a signal peptide and a conserved GAP
domain. The recombinant proteins have a similar level of GAP
activity and they interact with the same host targets, in agreement
with the conservation of critical interacting amino acid residues
[15]. Altogether, no qualitative difference was observed between
LbGAP and LbGAPy toxins in our functional assays that could
explain variation in virulence between virulent and avirulent
parasitoids. Occurrence of in vivo differences in protein binding or
activity in fly hemocytes cannot be ruled out but is very unlikely.
We previously showed that LbGAP is present in high amounts
inside lamellocytes of ISm parasitized hosts [15]. Following
Figure 5. LbGAP expression in ISm females is higher than
LbGAPy expression in ISy females. (A) Relative expression of LbGAP
(ISm line) and LbGAPy (ISy line) in venom-producing tissues compared
to the rest of the body without venom-producing tissues. (B) Ratio of
relative expression of LbGAP (ISm line) compared to LbGAPy (ISy line) in
venom-producing tissues and in the rest of the body without venom-
producing tissues. For each value, error bars represent the standard
error of three measurements.
doi:10.1371/journal.ppat.1001206.g005
Figure 6. LbGAP amount in ISm females is higher than LbGAPy
amount in ISy females. (A) Dot blot experiments on serial dilutions
of the recombinant proteins GST-LbGAP and GST-LbGAPy using a
LbGAP-specific polyclonal antibody. GST-tag alone was used as a
control. (B) Slot blot on serial dilution of protein extract starting from
twenty ISm and twenty ISy venom apparatus. (C) Slot blot on serial
dilution of protein extract starting from five ISm and five F1 hybrid
venom apparatus.
doi:10.1371/journal.ppat.1001206.g006
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lamellocytes, but in a much lower number of cells and, when
present, in a much lower quantity compared to LbGAP.
Moreover, the morphology of LbGAPy-containing lamellocytes
remained unchanged, in agreement with the previous observation
that LbGAP quantity in a cell correlates with the degree of shape
alteration [15]. LbGAP and LbGAPy are then both able to
‘‘enter’’ host hemocytes but the quantity of LbGAP in ISm venom
is 60-fold higher than that of LbGAPy in ISy venom. This
difference is sufficient to explain the difference in the amount of
the two toxins inside host lamellocytes. A different rate of entry
between LbGAP and LbGAPy in host cells cannot be ruled out
but it would not be detected given the low quantity of LbGAPy in
ISy venom. Such a high difference in quantity is probably
responsible for the absence of detection of LbGAPy in ISy venom
in a previous study [23]. Interestingly, the toxin amount in venom
was twice lower in F1 hybrids than in ISm parasitoids while F1
hybrids were as virulent as ISm on D. melanogaster resistant flies.
This also supports the idea that a minimal quantity of LbGAP is
necessary for L. boulardi success in resistant D. melanogaster, and
suggests the possible existence of a threshold effect on LbGAP/
LbGAPy quantity in the virulence phenotype.
The production of high amounts of LbGAP is probably under
strong selection in Mediterranean areas where resistant D.
melanogaster are often encountered as hosts [13]. The selection in
tropical Africa would be relaxed due to the occurrence of
alternative host species and to a possible cost of LbGAP
overproduction. The reason why no resistance to virulent
parasitoids has been described yet in D. melanogaster, while
resistance to avirulent parasitoids is found at high frequencies,
might be that resistance to injection of high amounts of LbGAP is
difficult to evolve. Rac GTPases, the targets of LbGAP, are highly
conserved proteins due to their key role in cell functions and target
modification is unlikely to evolve. Some removal of LbGAP from
the host hemolymph is performed via phagocytosis by host
plasmatocytes [15]. However, the high quantity of the LbGAP
injected, together with the fact that the toxin quickly enters host
lamellocytes, may encompass phagocytosis capacities. Evolution of
resistance would thus require evolution in the potential of
detoxification by host hemocyte cells or of degradation of the
toxin, for instance via host proteases. A connected question is the
reason why LbGAP is not efficient on D. yakuba lamellocytes in
spite of the total conservation of its Rac targets between the two
host species. Answers might involve differences in their intrinsic
potential of degradation of foreign proteins, the higher number of
hemocytes cells recorded in D. yakuba [42], or differences in
lamellocytes that would influence the capacity of ‘‘entry’’ of
LbGAP.
Differences in the RacGAP protein amounts in venom of the
two parasitoid lines were correlated with differences in the amount
of LbGAP/LbGAPy mRNA in venom-producing tissues, while we
found no difference in gene copy number using genomic DNA
from venom tissues or residual bodies. This allowed us to conclude
that variation in the RacGAP toxin between virulent and avirulent
strains is mainly quantitative. It likely results from differences in
regulation of gene transcription in venom-producing tissues, even
if the hypothesis of a difference in LbGAP and LbGAPy mRNA
stability cannot be totally ruled out.
One of the characteristics of most parasitoid venom proteins is
their high amount in venom compared to other tissues, which
often correlates with a high level of expression of their coding
genes [16],[43–50]. Here, we found a much higher mRNA level of
the RacGAP toxin in venom-producing tissues of the two
parasitoid lines than in the rest of the body. Such a tissue-specific
change of expression is one of the traits likely selected in the
process of re-use of a protein as a virulence factor, because such
factors need to be delivered into the host via injection of venom at
each oviposition event [51]. Transcription of the LbGAP/
LbGAPy gene is thus regulated both in a tissue-specific manner
and differently between virulent and avirulent strains.
Changes in gene regulation are now believed to play a
prominent role in evolution of biological diversity. Regulatory
factors that control gene expression are mainly transcription
factors that bind to cis-regulatory elements in the upstream
sequences of the gene, and microRNAs (miRNA) [52]. Specific
gene expression in parasitoid venom-producing tissues might be
driven by the availability of transcription factors that are tissue-
specific [53]. Differences in the binding level of transcription
factors to cis-regulating sequences might explain the different level
of expression between parasitoid lines. They could originate either
Figure 7. Variation of expression of LbGAP and LbGAPy. PCR experiments were performed on genomic DNA (+) to assess the specificity of the
LbGAP- and LbGAPy-specific primers, and on serial dilutions of cDNA templates (1, 1/10, 1/100) to determine whether the variation of expression of
LbGAP and LbGAPy is under the control of cis-o rtrans-acting elements. The ITS2 ribosomal sequence was used as control to assess the quantity of the
DNA and RNA samples. (2) Negative control.
doi:10.1371/journal.ppat.1001206.g007
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at the inter-specific level [54] or from variation in accessibility of
cis-regulating sequences [55]. In L. boulardi F1 individuals between
ISm and ISy strains, it is the LbGAP allele that is overexpressed in
the venom, the transcription of the LbGAPy allele remaining very
low. This result supports the hypothesis of variation in cis-
regulation of LbGAP expression. Full characterization of the
mechanisms involved in regulation of LbGAP transcription will
involve cloning and comparing upstream gene sequences and
promoter regions between parasitoid strains, characterizing
binding of transcription factors, and if necessary analyzing the
miRNA expressed in venom protein-secreting cells since changes
in miRNA-mediated gene regulation [52] can allow a quick and
reversible diversification of the gene expression program. This
would provide insights in understanding the mechanisms of
transcriptional evolution, currently under active investigation, at
the intra-species level.
The regulation of transcription of a venom factor reported
here is the first described mechanism at the origin of intraspecific
variation in immune suppressive properties of a parasite. An
open area of research is now to define how common is this
mechanism and whether its occurrence is linked to the nature of
the virulence factors, is in relation with the taxonomy, or might
be parasitoid specific. Parasitoids are major auxiliaries in the
control of insect pests and their host range and specificity are
widely discussed in the literature [56],[57]. Estimations of the
potential for evolution of virulence molecules and acquisition of
new virulence factors in a parasitoid species are essential
information to understand and improve the results of biological
control assays.
Materials and Methods
Biological material
The origins of the L. boulardi ISy (Gif stock number 486) and
ISm (Gif stock number 431) isofemale lines have been previously
described [41]. Briefly, ISy derives from a single female originating
from Brazzaville (Congo) while ISm derives from a single female
collected in Nasrallah (Tunisia). ISm females are highly virulent
against D. melanogaster while parasitism success of ISy females
depends on the resistant/susceptible genotype of the host [12]. L.
boulardi F1 hybrid females were obtained from crosses between
ISm females and ISy males. Both ISm and ISy lines, as well as F1
hybrids, were reared on a susceptible D. melanogaster strain (Gif
stock, number 1333), at 25uC. After emergence, adults of both
lines were kept at 18uC on agar medium with honey.
Parasitism experiments
For parasitism experiments, the D. melanogaster YR strain (Gif
stock, number 1088), resistant to L. boulardi ISy parasitoids, was
used as host [32]. In each experiment, 30 second-instar host larvae
(L2) were parasitized during 4 hours by one parasitoid female. The
encapsulation ability was estimated 48 hours later by counting the
number of encapsulated eggs after dissection of late third-instar
larvae. Virulence was expressed as the ratio of non-encapsulated
parasitoid eggs to the number of mono-parasitized hosts.
Injection experiments
The first injection experiment was performed using freshly
collected venom from ISm parasitoid females. The venom
apparatus of 20 individuals were carefully removed and placed
in 20 ml of Ringer’s saline solution. The sample was homogenized
manually in an Eppendorf tube and the extract was centrifuged at
5006g, 4uC for 5 min to eliminate the cellular debris. 10 ml of the
supernatant were then incubated during one hour at 4uC either
with the preimmune serum or the specific anti-LbGAP polyclonal
antibody, both diluted 1:10. Finally, 20 nl of the incubated venom
were injected in L2 D. melanogaster YR larvae using a Nanoject II
injector (Drummond Scientific Company, Broomall, PA). Ap-
proximately 180 larvae were injected then parasitized by ISy
parasitoid females as described above but during a two hours
period.
In the second injection experiment, 20 nl of the preimmune
serum or of the specific anti-LbGAP polyclonal antibody, both
diluted 1:10, were injected in approximately 180 L2 D. melanogaster
YR larvae which were then parasitized by ISm females as
described above.
Cloning and sequence analysis
To obtain the sequence of the LbGAPyc D N A ,t o t a lR N Aw a s
extracted from L. boulardi ISy venom producing tissues using the
TRIzol reagent (Invitrogen). RT-PCR was then performed using
two specific primers designed from the cDNA sequence of LbGAP
[23], 59-CATAATTTTCAAATCTTCAACTTTTTTAGA-39 and
59-TTAGTCTCTGCACTTTTTCTCA TTTGATGT-39.T h e
amplified fragments were cloned into the pCR2.1-TOPO vector
(Invitrogen) and sequenced.
Pairwise sequence comparisons were performed using the
EMBOSS program Needle at EMBL-EBI (http://www.ebi.ac.
uk/emboss/align/). The search for domains was performed using
CDD (Conserved Domain Database) at NCBI (http://www.ncbi.
nlm.nih.gov/ Structure/cdd/cdd.shtml) and InterProScan at
EMBL-EBI (http://www.ebi.ac.uk/ Tools/InterProScan/). Oc-
currence and position of the signal peptide cleavage site were
predicted using SignalP at CBS (http://www.cbs.dtu.dk/services/
SignalP/) and Phobius at SBC (http://phobius.sbc.su.se/).
In vitro GAP assays
In vitro GAP assays with recombinant GST-LbGAP and GST-
LbGAPy proteins were performed in triplicates using the RhoGAP
Assay Biochem Kit from Cytoskeleton Inc. P values were
generated by ANOVA followed by pairwise comparisons using
pairwise t tests performed with the R software package (http://
www.r-project.org/).
Yeast two-hybrid analysis
The LbGAPy cDNA was inserted into the pGADT7 vector by
homologous recombination in yeast strain JD53 (MATa, his3–200,
leu2–3112, lys2–801, trp1–63, ura3–52). Interactions between
LbGAP and mutated forms of RhoA, Rac1, Rac2 and Cdc42
GTPases were then examined individually by mating as previously
described [15]. The plasmids expressing GTPase proteins were
tested against the pGADT7 empty vector and the pGADT7-T
control vector that encodes a fusion between the GAL4 activation
domain and SV40 large T-antigen. Reciprocally, the plasmid
producing LbGAPy was tested against the pLex-Lamin control
vector. Interactions between LbGAP and Rac1 and Rac2
GTPases were used as positive controls [15]. Interactions were
first tested by spotting five-fold serial dilutions of cells on minimal
medium lacking histidine and supplemented with 3-amino-triazole
at 0.5 mM to reduce the number of false positives. Quantification
of ß-galactosidase activity in liquid assays was then performed
according to the Yeast Protocols Handbook PT3024-1 (Clontech
Laboratories, Inc.) except that yeast cells were lysed using glass
beads (Sigma). P values were generated by ANOVA followed by
pairwise comparisons using pairwise t tests performed with the R
software package.
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GST-LbGAP was produced using a previously obtained
construct [23] corresponding to the full-length LbGAP cDNA
(without the signal peptide) cloned into the pGEX-5X-1 vector
(GE Healthcare). For production of GST-LbGAPy, a cDNA
fragment corresponding to the mature LbGAPy protein was
amplified by RT-PCR from total RNA from ISy venom-
producing tissues. The amplified fragment was cloned into the
pGEX-4T-2 vector (GE Healthcare) using EcoRI and XhoI
restriction sites. Competent BL21 Escherichia coli cells were
subsequently transformed with the recombinant plasmids. The
production and purification of the GST-LbGAP and GST-
LbGAPy fusion proteins and GST alone were performed
according to the GST Gene Fusion System Handbook (GE
Healthcare).
Immunocytochemistry
Immunocytochemical experiments were performed as previous-
ly described [15], using a rabbit anti-LbGAP polyclonal antibody
[23] and Phalloidin-X5-FluoProbe 505 (Interchim) to visualize F-
actin.
Quantitative real-time RT-PCR
Total RNA was isolated either from dissected venom apparatus
or from the rest of the female bodies (without venom-producing
tissues) using the TRIzol reagent (Invitrogen), and reverse-
transcribed using the iScript cDNA Synthesis Kit (BioRad). qPCR
reactions were then carried out on an Opticon monitor 2 (BioRad)
using the Absolute qPCR SYBR MasterMix Plus for SYBR Green
I No ROX (Eurogentec) and the specific primers 59-TGAAA-
GGGCGAATAATTGATG-39 and 59-TTTGGTGGAAGTTT-
GGAA-39 for LbGAP and LbGAPy, respectively. PCR conditions
were as follows: 50uC for 2 min, 95uC for 10 min, followed by 40
cycles of 95uC for 30 s, 60uC for 30 s and 68uC for 30 s. Each
reaction was performed in triplicate and the mean of three
independent biological replicates (venom-producing tissues) or
two independent biological replicates (rest of the bodies) was
calculated. All data were normalized using the ITS2 (Internal
Transcribed Spacer 2) ribosomal sequence as a control and results
were analyzed using the DCt method. P values were generated by
Student’s t test with the R software package.
Quantitative real-time PCR
Genomic DNA was isolated either from dissected venom
apparatus or from the rest of female bodies (without venom
apparatus) using the DNeasy Blood & Tissue Kit (QIAGEN).
qPCR reactions were then carried out as described above. Each
reaction was performed in triplicate and the mean of three
independent biological replicates was calculated. All data were
normalized using the ITS2 ribosomal sequence as a control and
analyzed using qBase software (http://medgen.ugent.be/qbase/).
P values were generated by ANOVA followed by pairwise
comparisons using pairwise t tests performed with the R software
package.
PCR and RT-PCR experiments with primers specific to
LbGAP and LbGAPy
Genomic DNA isolation, total RNA isolation, and reverse
transcription were performed as described above. The specific
primer pairs were 59-CTCCTGAAGACAGTGTAGAAAT-
TATTC-39 and 59-GAATTTTTGAAACATCACTCGAAATA-
39 for LbGAP and 59-GCTCCT AAAGACAGTATAGCAAT-
TGTTA-39 and 59-AGATTAATTGAAACATCATCCGAAAT-
39 for LbGAPy. PCR was performed using GoTaq DNA Polymerase
(Promega) as follows: 94uC for 2 min, followed by 35 cycles of 94uC
for 30 s, 60uC for 30 s and 72uC for 45 s. Serial 1:10 dilutions were
used for cDNA templates. Amplification products were analyzed on a
2% ethidium bromide-stained agarose gel.
Blotting experiments
For dot blot experiments with recombinant GST-LbGAP and
GST-LbGAPy proteins, serial 1:5 dilutions, starting from 10 ng of
recombinant protein, were blotted onto a nitrocellulose mem-
brane. GST alone was used as a negative control. Non-specific
binding sites were blocked by overnight incubation at 4uC with
TBST-2% milk buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl,
0.3% Tween 20). The membrane was probed 1 h with the LbGAP
antiserum used at a 1:5000 dilution. After three washes with TBST
buffer, specifically bound antibodies were detected using anti-
rabbit IgG horseradish peroxidase conjugate (Sigma) used at a
1:15000 dilution for a 1 h incubation period. The membrane was
revealed using the chemiluminescent Immobilon Western sub-
strate (Millipore). Relative spot intensities were digitalized and
quantified using GeneSnap and GeneTools softwares (Syngene).
For slot blot experiments comparing ISm and ISy extracts, 20
female venom apparatus were dissected in 20 ml of Ringer’s
solution and centrifuged for 2 min at 5006g. The supernatant was
then diluted in 200 ml of denaturation solution (10 mM Tris-HCl
pH 8, 100 mM NaPO4, 8 M Urea) and blotted onto a
nitrocellulose membrane. For slot blot experiments comparing
ISm and F1 hybrid extracts, only 5 female venom apparatus were
used for each strain. The quantity of protein in the samples was
determined using the Coo Protein Assay (Biorad) and found to be
equivalent between the different parasitoid strains.
Accession numbers
The GenBank accession number for the nucleotide sequence of
LbGAPy is GU300066.
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